From Eurasia and Norway
Suven Life Sciences has been granted one (1) product patent from Eurasia (025136) and one (1) product patent from Norway (339034) corresponding to the New Chemical Entities (NCEs) for the treatment of disorders associated with Neurodegenerative diseases and these Patents are valid through 2032 and 2025 respectively.Powered by Capital Market - Live News